PKSGY yields 24.04% · PFE yields 6.13%● Live data
📍 PKSGY pulled ahead of the other in Year 1
Combined, PKSGY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PKSGY + PFE for your $10,000?
Parkson Retail Group Limited operates and manages a network of department stores, shopping malls, city outlets, supermarkets, and food and beverage outlets. The company offers various brands of fashion and lifestyle related merchandise focusing on four categories, which include fashion and apparel, cosmetics and accessories, household and electrical, and groceries and perishables targeting the young and contemporary market. As of December 31, 2021, it operated 43 Parkson stores, 2 Parkson Newcore city malls, and 1 Lion mall in 30 cities in the People's Republic of China. The company also provides consultancy and management, property management, and food and beverage management services, as well as consumer financing and trading services. In addition, it operates as a licensor for the Franco brand. The company was founded in 1994 and is headquartered in Shanghai, the People's Republic of China. Parkson Retail Group Limited is a subsidiary of PRG Corporation Limited.
Full PKSGY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.